Patents by Inventor Kristin S Eaton

Kristin S Eaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Interleukin-3 Polypeptide Conjugates and Their Uses
    Publication number: 20150038679
    Abstract: The disclosure provides methods for targeting interleukin-3 receptor-expressing cells, particularly inhibiting the growth of such cells by using an interleukin-3 (IL-3) variant conjugated to a toxin that will affect cells expressing the interleukin-3 receptor. Further disclosed are interleukin-3 (IL-3) variants comprising one or more non-naturally encoded amino acids, and the structures of non-naturally encoded amino acids.
    Type: Application
    Filed: February 28, 2013
    Publication date: February 5, 2015
    Applicant: Ambrx, Inc.
    Inventors: Melanie Nelson, Kristin S. Eaton
  • Interleukin-10 Polypeptide Conjugates and Their Uses
    Publication number: 20150038678
    Abstract: This invention relates to interleukin-10 (IL-10) polypeptide conjugates comprising at least one non-naturally-encoded amino acid.
    Type: Application
    Filed: February 28, 2013
    Publication date: February 5, 2015
    Applicant: Ambrx, Inc.
    Inventors: Kristin S. Eaton, Melanie Nelson
  • Modified FGF-23 Polypeptides and Their Uses
    Publication number: 20110015345
    Abstract: Modified FGF-23 polypeptides and uses thereof are provided.
    Type: Application
    Filed: March 19, 2009
    Publication date: January 20, 2011
    Applicant: AMBRX, INC.
    Inventors: Jason Pinkstaff, Anna-Maria A Hays Putnam, Kristin S Eaton